| Today's Eyecare, Llc | |
|
214 Southcity Pkwy Ste 103, Lafayette, LA 70503-5718 | |
| (337) 313-2020 | |
| (337) 362-0222 |
| Full Name | Today's Eyecare, Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 214 Southcity Pkwy Ste 103, Lafayette, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710007000 | NPI | - | NPPES |
| CB4965 | Other | LA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Catherine Guidry |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1992721252 PECOS PAC ID: 4587652524 Enrollment ID: I20040506000272 |
News Archive
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
Stryker Corporation's Orthopaedics' division today announced at the American Academy of Orthopaedic Surgeons Conference that its recent FDA-monitored Investigational Device Exemption study found no statistical difference in clinical outcomes between its mobile bearing and traditional fixed bearing knee systems. In contrast, Stryker continues to be very pleased with the success of its fixed bearing Triathlon Knee System with X3 Advanced Bearing Technology, which offers significant advantages over mobile bearing knees on wear rates and overall value.
We've known about chemicals that can be light-activated for about five to ten years now. They've mainly all been applied to neurons and, more specifically, the retina. Nobody has ever really looked at any tissues outside of the nervous system.
Joerns RecoverCare has launched ClimateCare; a unique mattress coverlet system that provides microclimate management. When used in conjunction with a pressure redistribution mattress, ClimateCare is designed to address the root causes of tissue breakdown through the management of temperature and moisture (microclimate) at the interface between the patient's skin and the therapy support surface.
A Johns Hopkins-led study of outcomes among 1,200 people with implanted defibrillators - devices intended to prevent sudden cardiac death from abnormal heart rhythms - shows that within a few years of implantation, one in four experienced improvements in heart function substantial enough to put them over the clinical threshold that qualified them to get a defibrillator in the first place.
› Verified 6 days ago
| Provider Name | Joseph A Atkins |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1346271384 PECOS PAC ID: 5597785238 Enrollment ID: I20051128000180 |
News Archive
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
Stryker Corporation's Orthopaedics' division today announced at the American Academy of Orthopaedic Surgeons Conference that its recent FDA-monitored Investigational Device Exemption study found no statistical difference in clinical outcomes between its mobile bearing and traditional fixed bearing knee systems. In contrast, Stryker continues to be very pleased with the success of its fixed bearing Triathlon Knee System with X3 Advanced Bearing Technology, which offers significant advantages over mobile bearing knees on wear rates and overall value.
We've known about chemicals that can be light-activated for about five to ten years now. They've mainly all been applied to neurons and, more specifically, the retina. Nobody has ever really looked at any tissues outside of the nervous system.
Joerns RecoverCare has launched ClimateCare; a unique mattress coverlet system that provides microclimate management. When used in conjunction with a pressure redistribution mattress, ClimateCare is designed to address the root causes of tissue breakdown through the management of temperature and moisture (microclimate) at the interface between the patient's skin and the therapy support surface.
A Johns Hopkins-led study of outcomes among 1,200 people with implanted defibrillators - devices intended to prevent sudden cardiac death from abnormal heart rhythms - shows that within a few years of implantation, one in four experienced improvements in heart function substantial enough to put them over the clinical threshold that qualified them to get a defibrillator in the first place.
› Verified 6 days ago
| Provider Name | Mitchell Broussard |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1013904473 PECOS PAC ID: 9133390362 Enrollment ID: I20110920000732 |
News Archive
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
Stryker Corporation's Orthopaedics' division today announced at the American Academy of Orthopaedic Surgeons Conference that its recent FDA-monitored Investigational Device Exemption study found no statistical difference in clinical outcomes between its mobile bearing and traditional fixed bearing knee systems. In contrast, Stryker continues to be very pleased with the success of its fixed bearing Triathlon Knee System with X3 Advanced Bearing Technology, which offers significant advantages over mobile bearing knees on wear rates and overall value.
We've known about chemicals that can be light-activated for about five to ten years now. They've mainly all been applied to neurons and, more specifically, the retina. Nobody has ever really looked at any tissues outside of the nervous system.
Joerns RecoverCare has launched ClimateCare; a unique mattress coverlet system that provides microclimate management. When used in conjunction with a pressure redistribution mattress, ClimateCare is designed to address the root causes of tissue breakdown through the management of temperature and moisture (microclimate) at the interface between the patient's skin and the therapy support surface.
A Johns Hopkins-led study of outcomes among 1,200 people with implanted defibrillators - devices intended to prevent sudden cardiac death from abnormal heart rhythms - shows that within a few years of implantation, one in four experienced improvements in heart function substantial enough to put them over the clinical threshold that qualified them to get a defibrillator in the first place.
› Verified 6 days ago
| Provider Name | Crystal M Gustin |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1073891024 PECOS PAC ID: 8527239466 Enrollment ID: I20110926000187 |
News Archive
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
Stryker Corporation's Orthopaedics' division today announced at the American Academy of Orthopaedic Surgeons Conference that its recent FDA-monitored Investigational Device Exemption study found no statistical difference in clinical outcomes between its mobile bearing and traditional fixed bearing knee systems. In contrast, Stryker continues to be very pleased with the success of its fixed bearing Triathlon Knee System with X3 Advanced Bearing Technology, which offers significant advantages over mobile bearing knees on wear rates and overall value.
We've known about chemicals that can be light-activated for about five to ten years now. They've mainly all been applied to neurons and, more specifically, the retina. Nobody has ever really looked at any tissues outside of the nervous system.
Joerns RecoverCare has launched ClimateCare; a unique mattress coverlet system that provides microclimate management. When used in conjunction with a pressure redistribution mattress, ClimateCare is designed to address the root causes of tissue breakdown through the management of temperature and moisture (microclimate) at the interface between the patient's skin and the therapy support surface.
A Johns Hopkins-led study of outcomes among 1,200 people with implanted defibrillators - devices intended to prevent sudden cardiac death from abnormal heart rhythms - shows that within a few years of implantation, one in four experienced improvements in heart function substantial enough to put them over the clinical threshold that qualified them to get a defibrillator in the first place.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Today's Eyecare, Llc 214 Southcity Pkwy Ste 103, Lafayette, LA 70503-5718 Ph: (337) 313-2020 | Today's Eyecare, Llc 214 Southcity Pkwy Ste 103, Lafayette, LA 70503-5718 Ph: (337) 313-2020 |
News Archive
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.
Stryker Corporation's Orthopaedics' division today announced at the American Academy of Orthopaedic Surgeons Conference that its recent FDA-monitored Investigational Device Exemption study found no statistical difference in clinical outcomes between its mobile bearing and traditional fixed bearing knee systems. In contrast, Stryker continues to be very pleased with the success of its fixed bearing Triathlon Knee System with X3 Advanced Bearing Technology, which offers significant advantages over mobile bearing knees on wear rates and overall value.
We've known about chemicals that can be light-activated for about five to ten years now. They've mainly all been applied to neurons and, more specifically, the retina. Nobody has ever really looked at any tissues outside of the nervous system.
Joerns RecoverCare has launched ClimateCare; a unique mattress coverlet system that provides microclimate management. When used in conjunction with a pressure redistribution mattress, ClimateCare is designed to address the root causes of tissue breakdown through the management of temperature and moisture (microclimate) at the interface between the patient's skin and the therapy support surface.
A Johns Hopkins-led study of outcomes among 1,200 people with implanted defibrillators - devices intended to prevent sudden cardiac death from abnormal heart rhythms - shows that within a few years of implantation, one in four experienced improvements in heart function substantial enough to put them over the clinical threshold that qualified them to get a defibrillator in the first place.
› Verified 6 days ago
Dr. Mitchell Neil Broussard, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5725 Johnston St, Suite 2314, Lafayette, LA 70503 Phone: 337-984-2410 Fax: 337-984-2416 | |
Dr. Shamekia Ann Nwafor, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3505 Ambassador Caffery Pkwy, Lafayette, LA 70503 Phone: 337-984-1488 | |
Louisiana Physicians Eyecare Group, A Professional Corporation Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5540 Johnston St Ste 101, Lafayette, LA 70503 Phone: 337-314-9020 Fax: 337-314-9021 | |
Crystal M Gustin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5725 Johnston St Ste 2314, Lafayette, LA 70503 Phone: 337-984-2140 Fax: 337-984-2416 | |
Sanders Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4432 Johnston Street, Lafayette, LA 70503 Phone: 337-984-9941 Fax: 337-984-8639 | |
Eye Care South, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5725 Johnston St Ofc, Lafayette, LA 70503 Phone: 337-989-0515 | |
Richard J Piccione Md Apmc Optometrist Medicare: Medicare Enrolled Practice Location: 4906 Ambassador Caffery Pkwy, Ste. 701, Lafayette, LA 70508 Phone: 337-989-2600 Fax: 337-989-2601 |